APP and Alzheimer disease: Recent advances in molecular pathology and human genetics have reinforced the amyloid hypothesis for the etiology of AD: that the accumulation of Aβ peptide (produced by cleavage of APP by BACE1 and the γ-secretase complex) is the key initiator of AD pathogenesis [4]–[7].